

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 8.22065887 |
| 2 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 7.37581196 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 7.37581196 |
| 4 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 6.28571481 |
| 5 | ribosomal small subunit assembly (GO:0000028) | 6.25295317 |
| 6 | respiratory electron transport chain (GO:0022904) | 6.10152426 |
| 7 | electron transport chain (GO:0022900) | 6.00341193 |
| 8 | DNA deamination (GO:0045006) | 5.74400727 |
| 9 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 5.58770493 |
| 10 | proteasome assembly (GO:0043248) | 4.63254494 |
| 11 | protein neddylation (GO:0045116) | 4.42841849 |
| 12 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.22722861 |
| 13 | hydrogen ion transmembrane transport (GO:1902600) | 4.20665158 |
| 14 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.20206808 |
| 15 | viral transcription (GO:0019083) | 4.18216825 |
| 16 | ATP biosynthetic process (GO:0006754) | 4.16905461 |
| 17 | translational termination (GO:0006415) | 4.07821591 |
| 18 | cotranslational protein targeting to membrane (GO:0006613) | 4.07304046 |
| 19 | protein targeting to ER (GO:0045047) | 4.04309183 |
| 20 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.99987245 |
| 21 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.98544975 |
| 22 | protein localization to endoplasmic reticulum (GO:0070972) | 3.92082388 |
| 23 | signal peptide processing (GO:0006465) | 3.88114592 |
| 24 | response to interferon-beta (GO:0035456) | 3.84851340 |
| 25 | proton transport (GO:0015992) | 3.81523082 |
| 26 | translational elongation (GO:0006414) | 3.79609960 |
| 27 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.78648979 |
| 28 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.78575794 |
| 29 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.78475277 |
| 30 | hydrogen transport (GO:0006818) | 3.74172954 |
| 31 | protein targeting to mitochondrion (GO:0006626) | 3.72708460 |
| 32 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.69449176 |
| 33 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.67420782 |
| 34 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.67420782 |
| 35 | establishment of protein localization to mitochondrion (GO:0072655) | 3.60660732 |
| 36 | formation of translation preinitiation complex (GO:0001731) | 3.57288763 |
| 37 | ribosomal small subunit biogenesis (GO:0042274) | 3.55875746 |
| 38 | maturation of SSU-rRNA (GO:0030490) | 3.55530298 |
| 39 | inner mitochondrial membrane organization (GO:0007007) | 3.54851420 |
| 40 | protein localization to mitochondrion (GO:0070585) | 3.50734282 |
| 41 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.49358946 |
| 42 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.48392342 |
| 43 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.48118261 |
| 44 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.45186236 |
| 45 | sequestering of actin monomers (GO:0042989) | 3.45052044 |
| 46 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.43691157 |
| 47 | translation (GO:0006412) | 3.43169393 |
| 48 | pseudouridine synthesis (GO:0001522) | 3.40770459 |
| 49 | negative regulation of ligase activity (GO:0051352) | 3.40635415 |
| 50 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.40635415 |
| 51 | GTP biosynthetic process (GO:0006183) | 3.40403433 |
| 52 | protein-cofactor linkage (GO:0018065) | 3.38319264 |
| 53 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.37829259 |
| 54 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.37829259 |
| 55 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.37754725 |
| 56 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.37486061 |
| 57 | mannosylation (GO:0097502) | 3.37354999 |
| 58 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.36855204 |
| 59 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.36855204 |
| 60 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.36855204 |
| 61 | viral life cycle (GO:0019058) | 3.33721000 |
| 62 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.31811128 |
| 63 | translational initiation (GO:0006413) | 3.31300495 |
| 64 | iron-sulfur cluster assembly (GO:0016226) | 3.30388349 |
| 65 | metallo-sulfur cluster assembly (GO:0031163) | 3.30388349 |
| 66 | base-excision repair, AP site formation (GO:0006285) | 3.25114108 |
| 67 | respiratory chain complex IV assembly (GO:0008535) | 3.22790303 |
| 68 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.20052388 |
| 69 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.20052388 |
| 70 | mitochondrial transport (GO:0006839) | 3.19563203 |
| 71 | cytochrome complex assembly (GO:0017004) | 3.18258687 |
| 72 | termination of RNA polymerase III transcription (GO:0006386) | 3.18140195 |
| 73 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.18140195 |
| 74 | regulation of cellular amine metabolic process (GO:0033238) | 3.17641601 |
| 75 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.16434915 |
| 76 | intracellular protein transmembrane import (GO:0044743) | 3.16091204 |
| 77 | purine-containing compound salvage (GO:0043101) | 3.15297244 |
| 78 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.14993725 |
| 79 | cellular protein complex disassembly (GO:0043624) | 3.14942721 |
| 80 | ribosomal large subunit biogenesis (GO:0042273) | 3.13890454 |
| 81 | nucleoside triphosphate biosynthetic process (GO:0009142) | 3.13320628 |
| 82 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.13088321 |
| 83 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.13001887 |
| 84 | GDP-mannose metabolic process (GO:0019673) | 3.12797327 |
| 85 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.08644203 |
| 86 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.08408169 |
| 87 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.07309436 |
| 88 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.07065923 |
| 89 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.07065923 |
| 90 | telomere maintenance via recombination (GO:0000722) | 3.06007714 |
| 91 | DNA strand elongation (GO:0022616) | 3.05210788 |
| 92 | protein deneddylation (GO:0000338) | 3.03126393 |
| 93 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.01241739 |
| 94 | protein maturation by protein folding (GO:0022417) | 2.99963690 |
| 95 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.99205214 |
| 96 | regulation of mitochondrial translation (GO:0070129) | 2.96633926 |
| 97 | oxidative phosphorylation (GO:0006119) | 2.95053361 |
| 98 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.94632971 |
| 99 | cullin deneddylation (GO:0010388) | 2.91164500 |
| 100 | protein complex biogenesis (GO:0070271) | 2.90646241 |
| 101 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.89618826 |
| 102 | chaperone-mediated protein transport (GO:0072321) | 2.89429725 |
| 103 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.89302597 |
| 104 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.85443562 |
| 105 | positive regulation of ligase activity (GO:0051351) | 2.84725514 |
| 106 | rRNA modification (GO:0000154) | 2.84114852 |
| 107 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.80358197 |
| 108 | platelet dense granule organization (GO:0060155) | 2.78067809 |
| 109 | 7-methylguanosine mRNA capping (GO:0006370) | 2.77504440 |
| 110 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.74033302 |
| 111 | protein complex disassembly (GO:0043241) | 2.72660910 |
| 112 | 7-methylguanosine RNA capping (GO:0009452) | 2.72202153 |
| 113 | RNA capping (GO:0036260) | 2.72202153 |
| 114 | endosome to melanosome transport (GO:0035646) | 2.71265826 |
| 115 | endosome to pigment granule transport (GO:0043485) | 2.71265826 |
| 116 | positive regulation of cell cycle arrest (GO:0071158) | 2.71135132 |
| 117 | L-methionine salvage (GO:0071267) | 2.70710999 |
| 118 | L-methionine biosynthetic process (GO:0071265) | 2.70710999 |
| 119 | amino acid salvage (GO:0043102) | 2.70710999 |
| 120 | cellular component biogenesis (GO:0044085) | 2.69055581 |
| 121 | cellular response to interferon-beta (GO:0035458) | 2.68842440 |
| 122 | peptidyl-histidine modification (GO:0018202) | 2.68401633 |
| 123 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.65498246 |
| 124 | protein targeting to membrane (GO:0006612) | 2.65480543 |
| 125 | spliceosomal snRNP assembly (GO:0000387) | 2.63935841 |
| 126 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.61922672 |
| 127 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.61487189 |
| 128 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.61315444 |
| 129 | macromolecular complex disassembly (GO:0032984) | 2.60315378 |
| 130 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.59926219 |
| 131 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.59926219 |
| 132 | NADH dehydrogenase complex assembly (GO:0010257) | 2.59926219 |
| 133 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.56728905 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.05513808 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.80851406 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.56058435 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.51790500 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.51632044 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.45488619 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.35143493 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.24751545 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.18123713 |
| 10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.95624644 |
| 11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.71216548 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.67054448 |
| 13 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.57927273 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.54219985 |
| 15 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.53976295 |
| 16 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.51655445 |
| 17 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.36750793 |
| 18 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.32046036 |
| 19 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.30620075 |
| 20 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.30500564 |
| 21 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.27269261 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.24255173 |
| 23 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.19200812 |
| 24 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.13222486 |
| 25 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.10808789 |
| 26 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.10567590 |
| 27 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.01316357 |
| 28 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.00617832 |
| 29 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.99227957 |
| 30 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.95835428 |
| 31 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.95829044 |
| 32 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.92923231 |
| 33 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.88285639 |
| 34 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.86234776 |
| 35 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.84476041 |
| 36 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.81218129 |
| 37 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.79356127 |
| 38 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.73827716 |
| 39 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.72626290 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71393177 |
| 41 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70904027 |
| 42 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.70686986 |
| 43 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.70570377 |
| 44 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.70358729 |
| 45 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.68901303 |
| 46 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.63287182 |
| 47 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.61878684 |
| 48 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.61710951 |
| 49 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.61406452 |
| 50 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.61139965 |
| 51 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.60971040 |
| 52 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.49530066 |
| 53 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.48504343 |
| 54 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.46339001 |
| 55 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.45192231 |
| 56 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.44926179 |
| 57 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.44523264 |
| 58 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.41799755 |
| 59 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.39873303 |
| 60 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.38448481 |
| 61 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.35166787 |
| 62 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.34912337 |
| 63 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.33715567 |
| 64 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.33596576 |
| 65 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.33546444 |
| 66 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.32808290 |
| 67 | MYC_22102868_ChIP-Seq_BL_Human | 1.30965489 |
| 68 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.29207022 |
| 69 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.28136953 |
| 70 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.27126088 |
| 71 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26742600 |
| 72 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.26165388 |
| 73 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.23496982 |
| 74 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.23362651 |
| 75 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.19432365 |
| 76 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.17884990 |
| 77 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.17072489 |
| 78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17012749 |
| 79 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.16982886 |
| 80 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.14273915 |
| 81 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.13916868 |
| 82 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.12447615 |
| 83 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.11621046 |
| 84 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.11539266 |
| 85 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.10599949 |
| 86 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.09696164 |
| 87 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.07945423 |
| 88 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07148589 |
| 89 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.06720031 |
| 90 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.06162875 |
| 91 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05872362 |
| 92 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.03349322 |
| 93 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.03236083 |
| 94 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.02903546 |
| 95 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.02084440 |
| 96 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.02037629 |
| 97 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.01037687 |
| 98 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00979253 |
| 99 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.00945303 |
| 100 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.00259114 |
| 101 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.99478267 |
| 102 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.98919492 |
| 103 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.98820046 |
| 104 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98214678 |
| 105 | VDR_22108803_ChIP-Seq_LS180_Human | 0.96711679 |
| 106 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.95560083 |
| 107 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.95293441 |
| 108 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.95122778 |
| 109 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.94345193 |
| 110 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.94310218 |
| 111 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.93023597 |
| 112 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92837312 |
| 113 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.92338375 |
| 114 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.92051592 |
| 115 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.91411319 |
| 116 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.91408904 |
| 117 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.91218637 |
| 118 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.90985879 |
| 119 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.90832274 |
| 120 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.89334267 |
| 121 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.89061858 |
| 122 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.88962748 |
| 123 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.88898401 |
| 124 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.87643577 |
| 125 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86846661 |
| 126 | AR_20517297_ChIP-Seq_VCAP_Human | 0.86027874 |
| 127 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.85852577 |
| 128 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.85719652 |
| 129 | ERA_21632823_ChIP-Seq_H3396_Human | 0.84349126 |
| 130 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.82084282 |
| 131 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.81819676 |
| 132 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.77521753 |
| 133 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.77358173 |
| 134 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.76788899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.24621508 |
| 2 | MP0003693_abnormal_embryo_hatching | 3.20746551 |
| 3 | MP0003186_abnormal_redox_activity | 3.15875379 |
| 4 | MP0002396_abnormal_hematopoietic_system | 2.70683638 |
| 5 | MP0003436_decreased_susceptibility_to | 2.67477493 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 2.59819973 |
| 7 | MP0009785_altered_susceptibility_to | 2.59097120 |
| 8 | MP0001905_abnormal_dopamine_level | 2.57434835 |
| 9 | MP0003724_increased_susceptibility_to | 2.54720361 |
| 10 | MP0005671_abnormal_response_to | 2.54675769 |
| 11 | MP0003011_delayed_dark_adaptation | 2.37413935 |
| 12 | MP0001529_abnormal_vocalization | 2.35303001 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.34241421 |
| 14 | MP0001853_heart_inflammation | 2.33956904 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 2.31824809 |
| 16 | MP0002653_abnormal_ependyma_morphology | 2.26832229 |
| 17 | MP0003806_abnormal_nucleotide_metabolis | 2.25297157 |
| 18 | MP0009333_abnormal_splenocyte_physiolog | 2.24847288 |
| 19 | MP0003656_abnormal_erythrocyte_physiolo | 2.22138548 |
| 20 | MP0000685_abnormal_immune_system | 2.20003480 |
| 21 | MP0003136_yellow_coat_color | 2.18619959 |
| 22 | MP0001545_abnormal_hematopoietic_system | 2.17829155 |
| 23 | MP0005397_hematopoietic_system_phenotyp | 2.17829155 |
| 24 | MP0003763_abnormal_thymus_physiology | 2.15040408 |
| 25 | MP0005025_abnormal_response_to | 2.11626943 |
| 26 | MP0005000_abnormal_immune_tolerance | 2.02313529 |
| 27 | MP0006072_abnormal_retinal_apoptosis | 1.98959576 |
| 28 | MP0004957_abnormal_blastocyst_morpholog | 1.93619789 |
| 29 | MP0004808_abnormal_hematopoietic_stem | 1.87593869 |
| 30 | MP0002132_abnormal_respiratory_system | 1.86273912 |
| 31 | MP0008995_early_reproductive_senescence | 1.86126606 |
| 32 | MP0002419_abnormal_innate_immunity | 1.85529452 |
| 33 | MP0002398_abnormal_bone_marrow | 1.79630353 |
| 34 | MP0000490_abnormal_crypts_of | 1.78034717 |
| 35 | MP0002736_abnormal_nociception_after | 1.77324306 |
| 36 | MP0002723_abnormal_immune_serum | 1.77097791 |
| 37 | MP0006292_abnormal_olfactory_placode | 1.76610110 |
| 38 | MP0003718_maternal_effect | 1.74320361 |
| 39 | MP0010386_abnormal_urinary_bladder | 1.73815885 |
| 40 | MP0002452_abnormal_antigen_presenting | 1.73412933 |
| 41 | MP0008789_abnormal_olfactory_epithelium | 1.73049703 |
| 42 | MP0002420_abnormal_adaptive_immunity | 1.71741767 |
| 43 | MP0001800_abnormal_humoral_immune | 1.70522656 |
| 44 | MP0003077_abnormal_cell_cycle | 1.70363818 |
| 45 | MP0001819_abnormal_immune_cell | 1.69956218 |
| 46 | MP0006036_abnormal_mitochondrial_physio | 1.69286082 |
| 47 | MP0005464_abnormal_platelet_physiology | 1.67940713 |
| 48 | MP0004142_abnormal_muscle_tone | 1.64125738 |
| 49 | MP0002277_abnormal_respiratory_mucosa | 1.60918070 |
| 50 | MP0005075_abnormal_melanosome_morpholog | 1.59292728 |
| 51 | MP0006054_spinal_hemorrhage | 1.58909720 |
| 52 | MP0002405_respiratory_system_inflammati | 1.58092443 |
| 53 | MP0010094_abnormal_chromosome_stability | 1.57356015 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.56653263 |
| 55 | MP0003195_calcinosis | 1.56087540 |
| 56 | MP0008058_abnormal_DNA_repair | 1.54996478 |
| 57 | MP0010030_abnormal_orbit_morphology | 1.54446849 |
| 58 | MP0000716_abnormal_immune_system | 1.54045640 |
| 59 | MP0002722_abnormal_immune_system | 1.53721350 |
| 60 | MP0002429_abnormal_blood_cell | 1.53531555 |
| 61 | MP0002822_catalepsy | 1.52446772 |
| 62 | MP0004147_increased_porphyrin_level | 1.52176283 |
| 63 | MP0008007_abnormal_cellular_replicative | 1.47988942 |
| 64 | MP0001968_abnormal_touch/_nociception | 1.45394892 |
| 65 | MP0005551_abnormal_eye_electrophysiolog | 1.44971824 |
| 66 | MP0003880_abnormal_central_pattern | 1.44912013 |
| 67 | MP0001845_abnormal_inflammatory_respons | 1.41392631 |
| 68 | MP0008469_abnormal_protein_level | 1.40840071 |
| 69 | MP0001533_abnormal_skeleton_physiology | 1.40425075 |
| 70 | MP0005645_abnormal_hypothalamus_physiol | 1.39621648 |
| 71 | MP0003111_abnormal_nucleus_morphology | 1.39104340 |
| 72 | MP0002163_abnormal_gland_morphology | 1.39061984 |
| 73 | MP0008872_abnormal_physiological_respon | 1.36531426 |
| 74 | MP0000372_irregular_coat_pigmentation | 1.35700788 |
| 75 | MP0005387_immune_system_phenotype | 1.32018594 |
| 76 | MP0001790_abnormal_immune_system | 1.32018594 |
| 77 | MP0005084_abnormal_gallbladder_morpholo | 1.30170087 |
| 78 | MP0005332_abnormal_amino_acid | 1.28575048 |
| 79 | MP0002638_abnormal_pupillary_reflex | 1.25913908 |
| 80 | MP0005253_abnormal_eye_physiology | 1.25616227 |
| 81 | MP0002933_joint_inflammation | 1.23162193 |
| 82 | MP0009697_abnormal_copulation | 1.22718611 |
| 83 | MP0003786_premature_aging | 1.22539152 |
| 84 | MP0004133_heterotaxia | 1.22492334 |
| 85 | MP0005646_abnormal_pituitary_gland | 1.22301796 |
| 86 | MP0000343_altered_response_to | 1.20908985 |
| 87 | MP0006276_abnormal_autonomic_nervous | 1.20644269 |
| 88 | MP0008932_abnormal_embryonic_tissue | 1.20543924 |
| 89 | MP0006082_CNS_inflammation | 1.20495092 |
| 90 | MP0003866_abnormal_defecation | 1.19785417 |
| 91 | MP0000858_altered_metastatic_potential | 1.18211653 |
| 92 | MP0005058_abnormal_lysosome_morphology | 1.18061115 |
| 93 | MP0010155_abnormal_intestine_physiology | 1.16354500 |
| 94 | MP0001873_stomach_inflammation | 1.15814058 |
| 95 | MP0001986_abnormal_taste_sensitivity | 1.14981488 |
| 96 | MP0002019_abnormal_tumor_incidence | 1.13575807 |
| 97 | MP0009379_abnormal_foot_pigmentation | 1.12440738 |
| 98 | MP0002166_altered_tumor_susceptibility | 1.11904294 |
| 99 | MP0001764_abnormal_homeostasis | 1.11614080 |
| 100 | MP0002102_abnormal_ear_morphology | 1.09866169 |
| 101 | MP0000703_abnormal_thymus_morphology | 1.08592604 |
| 102 | MP0000313_abnormal_cell_death | 1.07771947 |
| 103 | MP0005171_absent_coat_pigmentation | 1.07637750 |
| 104 | MP0001756_abnormal_urination | 1.06224172 |
| 105 | MP0009764_decreased_sensitivity_to | 1.05693338 |
| 106 | MP0000631_abnormal_neuroendocrine_gland | 1.05369806 |
| 107 | MP0002006_tumorigenesis | 1.04448991 |
| 108 | MP0000465_gastrointestinal_hemorrhage | 1.03509734 |
| 109 | MP0003943_abnormal_hepatobiliary_system | 1.03460489 |
| 110 | MP0004782_abnormal_surfactant_physiolog | 0.96750345 |
| 111 | MP0005174_abnormal_tail_pigmentation | 0.96150399 |
| 112 | MP0002877_abnormal_melanocyte_morpholog | 0.94354408 |
| 113 | MP0005410_abnormal_fertilization | 0.93836570 |
| 114 | MP0005319_abnormal_enzyme/_coenzyme | 0.93335883 |
| 115 | MP0000681_abnormal_thyroid_gland | 0.91683734 |
| 116 | MP0009745_abnormal_behavioral_response | 0.91634306 |
| 117 | MP0001984_abnormal_olfaction | 0.91262100 |
| 118 | MP0000358_abnormal_cell_content/ | 0.90848518 |
| 119 | MP0000015_abnormal_ear_pigmentation | 0.89054526 |
| 120 | MP0009046_muscle_twitch | 0.88994839 |
| 121 | MP0001542_abnormal_bone_strength | 0.88980940 |
| 122 | MP0000516_abnormal_urinary_system | 0.87929079 |
| 123 | MP0005367_renal/urinary_system_phenotyp | 0.87929079 |
| 124 | MP0005390_skeleton_phenotype | 0.85675251 |
| 125 | MP0002234_abnormal_pharynx_morphology | 0.85393090 |
| 126 | MP0005636_abnormal_mineral_homeostasis | 0.85205243 |
| 127 | MP0005379_endocrine/exocrine_gland_phen | 0.84931387 |
| 128 | MP0003123_paternal_imprinting | 0.84400380 |
| 129 | MP0009840_abnormal_foam_cell | 0.84060697 |
| 130 | MP0005499_abnormal_olfactory_system | 0.83206491 |
| 131 | MP0005394_taste/olfaction_phenotype | 0.83206491 |
| 132 | MP0003121_genomic_imprinting | 0.82606210 |
| 133 | MP0002876_abnormal_thyroid_physiology | 0.81151935 |
| 134 | MP0003279_aneurysm | 0.81044562 |
| 135 | MP0000538_abnormal_urinary_bladder | 0.80580656 |
| 136 | MP0000598_abnormal_liver_morphology | 0.80199452 |
| 137 | MP0006035_abnormal_mitochondrial_morpho | 0.79516487 |
| 138 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.79497714 |
| 139 | MP0000750_abnormal_muscle_regeneration | 0.79183427 |
| 140 | MP0002210_abnormal_sex_determination | 0.78698234 |
| 141 | MP0001970_abnormal_pain_threshold | 0.78543729 |
| 142 | MP0000749_muscle_degeneration | 0.78057717 |
| 143 | MP0005389_reproductive_system_phenotype | 0.76820943 |
| 144 | MP0002272_abnormal_nervous_system | 0.76536812 |
| 145 | MP0002282_abnormal_trachea_morphology | 0.75942089 |
| 146 | MP0004019_abnormal_vitamin_homeostasis | 0.74810235 |
| 147 | MP0001293_anophthalmia | 0.74360268 |
| 148 | MP0009643_abnormal_urine_homeostasis | 0.74286415 |
| 149 | MP0003638_abnormal_response/metabolism_ | 0.73683042 |
| 150 | MP0005360_urolithiasis | 0.72687293 |
| 151 | MP0002693_abnormal_pancreas_physiology | 0.71370980 |
| 152 | MP0008877_abnormal_DNA_methylation | 0.71238278 |
| 153 | MP0001663_abnormal_digestive_system | 0.69008296 |
| 154 | MP0005377_hearing/vestibular/ear_phenot | 0.68433631 |
| 155 | MP0003878_abnormal_ear_physiology | 0.68433631 |
| 156 | MP0002095_abnormal_skin_pigmentation | 0.67877160 |
| 157 | MP0005423_abnormal_somatic_nervous | 0.67047205 |
| 158 | MP0002160_abnormal_reproductive_system | 0.66886721 |
| 159 | MP0001929_abnormal_gametogenesis | 0.66344896 |
| 160 | MP0005408_hypopigmentation | 0.66062483 |
| 161 | MP0000026_abnormal_inner_ear | 0.66001735 |
| 162 | MP0002928_abnormal_bile_duct | 0.65897461 |
| 163 | MP0008873_increased_physiological_sensi | 0.65721662 |
| 164 | MP0002938_white_spotting | 0.65708216 |
| 165 | MP0005083_abnormal_biliary_tract | 0.64380198 |
| 166 | MP0005365_abnormal_bile_salt | 0.61193734 |
| 167 | MP0009763_increased_sensitivity_to | 0.60740358 |
| 168 | MP0008057_abnormal_DNA_replication | 0.60651272 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal number of erythroid precursors (HP:0012131) | 4.47242211 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.42778570 |
| 3 | Aplastic anemia (HP:0001915) | 4.34418966 |
| 4 | Type I transferrin isoform profile (HP:0003642) | 3.97117440 |
| 5 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.79253275 |
| 6 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.79253275 |
| 7 | Hepatic necrosis (HP:0002605) | 3.48415692 |
| 8 | Petechiae (HP:0000967) | 3.43960784 |
| 9 | Hepatocellular necrosis (HP:0001404) | 3.42616801 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.40384204 |
| 11 | Thrombocytosis (HP:0001894) | 3.38191343 |
| 12 | Mitochondrial inheritance (HP:0001427) | 3.37383123 |
| 13 | Reticulocytopenia (HP:0001896) | 3.32873621 |
| 14 | Reduced antithrombin III activity (HP:0001976) | 3.27865329 |
| 15 | Optic disc pallor (HP:0000543) | 3.22622276 |
| 16 | 3-Methylglutaconic aciduria (HP:0003535) | 3.17148720 |
| 17 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.13726054 |
| 18 | Increased CSF lactate (HP:0002490) | 3.08504142 |
| 19 | Acute necrotizing encephalopathy (HP:0006965) | 3.01288127 |
| 20 | Poor head control (HP:0002421) | 2.98465830 |
| 21 | Abnormal glycosylation (HP:0012345) | 2.96152919 |
| 22 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.96152919 |
| 23 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.96152919 |
| 24 | Abnormal protein glycosylation (HP:0012346) | 2.96152919 |
| 25 | Increased hepatocellular lipid droplets (HP:0006565) | 2.96089775 |
| 26 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.89411029 |
| 27 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.88155716 |
| 28 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.87435770 |
| 29 | Lipid accumulation in hepatocytes (HP:0006561) | 2.86606861 |
| 30 | Exertional dyspnea (HP:0002875) | 2.84087052 |
| 31 | Increased serum lactate (HP:0002151) | 2.83299499 |
| 32 | Generalized aminoaciduria (HP:0002909) | 2.82096677 |
| 33 | Increased intramyocellular lipid droplets (HP:0012240) | 2.80308598 |
| 34 | Congenital, generalized hypertrichosis (HP:0004540) | 2.79747229 |
| 35 | Renal Fanconi syndrome (HP:0001994) | 2.77131182 |
| 36 | Degeneration of anterior horn cells (HP:0002398) | 2.71198169 |
| 37 | Abnormality of the anterior horn cell (HP:0006802) | 2.71198169 |
| 38 | Emotional lability (HP:0000712) | 2.68837730 |
| 39 | IgM deficiency (HP:0002850) | 2.67486973 |
| 40 | Lethargy (HP:0001254) | 2.65475101 |
| 41 | Methylmalonic aciduria (HP:0012120) | 2.61911330 |
| 42 | Increased muscle lipid content (HP:0009058) | 2.58882868 |
| 43 | Lactic acidosis (HP:0003128) | 2.56590364 |
| 44 | Recurrent abscess formation (HP:0002722) | 2.55259733 |
| 45 | CNS demyelination (HP:0007305) | 2.54214909 |
| 46 | Leukodystrophy (HP:0002415) | 2.51120170 |
| 47 | Pallor (HP:0000980) | 2.47792432 |
| 48 | Acute encephalopathy (HP:0006846) | 2.46498570 |
| 49 | Testicular atrophy (HP:0000029) | 2.46335473 |
| 50 | Medial flaring of the eyebrow (HP:0010747) | 2.44928117 |
| 51 | Vacuolated lymphocytes (HP:0001922) | 2.44818165 |
| 52 | Oral leukoplakia (HP:0002745) | 2.42881422 |
| 53 | Recurrent bacterial skin infections (HP:0005406) | 2.42749760 |
| 54 | Respiratory difficulties (HP:0002880) | 2.41606453 |
| 55 | Pancreatic cysts (HP:0001737) | 2.38563631 |
| 56 | Muscle fiber atrophy (HP:0100295) | 2.36666997 |
| 57 | Type 2 muscle fiber atrophy (HP:0003554) | 2.35409488 |
| 58 | Hypothermia (HP:0002045) | 2.34804383 |
| 59 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.34800795 |
| 60 | Dicarboxylic aciduria (HP:0003215) | 2.34800795 |
| 61 | Myositis (HP:0100614) | 2.32062335 |
| 62 | Vertebral compression fractures (HP:0002953) | 2.30349293 |
| 63 | Hyperphosphaturia (HP:0003109) | 2.30332045 |
| 64 | Microretrognathia (HP:0000308) | 2.29688028 |
| 65 | Abnormality of midbrain morphology (HP:0002418) | 2.26872557 |
| 66 | Molar tooth sign on MRI (HP:0002419) | 2.26872557 |
| 67 | Pancytopenia (HP:0001876) | 2.26275718 |
| 68 | Nausea (HP:0002018) | 2.23388460 |
| 69 | Methylmalonic acidemia (HP:0002912) | 2.20984945 |
| 70 | X-linked dominant inheritance (HP:0001423) | 2.19124067 |
| 71 | True hermaphroditism (HP:0010459) | 2.18944659 |
| 72 | Exercise intolerance (HP:0003546) | 2.18489414 |
| 73 | Eczematoid dermatitis (HP:0000976) | 2.16484189 |
| 74 | Beaking of vertebral bodies (HP:0004568) | 2.16095546 |
| 75 | Progressive macrocephaly (HP:0004481) | 2.15298370 |
| 76 | Pancreatic fibrosis (HP:0100732) | 2.15176304 |
| 77 | Macrocytic anemia (HP:0001972) | 2.08851241 |
| 78 | Abnormality of T cell physiology (HP:0011840) | 2.07944246 |
| 79 | Esophageal neoplasm (HP:0100751) | 2.07459946 |
| 80 | Neoplasm of head and neck (HP:0012288) | 2.07459946 |
| 81 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.07417514 |
| 82 | Abnormal pupillary function (HP:0007686) | 2.06534609 |
| 83 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.04276061 |
| 84 | Respiratory failure (HP:0002878) | 2.04254820 |
| 85 | Rough bone trabeculation (HP:0100670) | 2.03793166 |
| 86 | Purpura (HP:0000979) | 2.02690766 |
| 87 | Neutropenia (HP:0001875) | 2.00939658 |
| 88 | Prolonged bleeding time (HP:0003010) | 1.99456588 |
| 89 | Birth length less than 3rd percentile (HP:0003561) | 1.99335401 |
| 90 | Optic nerve coloboma (HP:0000588) | 1.97629612 |
| 91 | Microvesicular hepatic steatosis (HP:0001414) | 1.97583407 |
| 92 | Delayed CNS myelination (HP:0002188) | 1.97469323 |
| 93 | Premature graying of hair (HP:0002216) | 1.90907651 |
| 94 | Congenital stationary night blindness (HP:0007642) | 1.90412983 |
| 95 | Opisthotonus (HP:0002179) | 1.89151348 |
| 96 | Irregular epiphyses (HP:0010582) | 1.87055079 |
| 97 | Increased serum pyruvate (HP:0003542) | 1.86904189 |
| 98 | Nephrogenic diabetes insipidus (HP:0009806) | 1.86865563 |
| 99 | Blindness (HP:0000618) | 1.86803396 |
| 100 | Hyperglycinemia (HP:0002154) | 1.86147677 |
| 101 | Abnormality of macrophages (HP:0004311) | 1.85815483 |
| 102 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.85768056 |
| 103 | Congenital primary aphakia (HP:0007707) | 1.85587503 |
| 104 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.84596471 |
| 105 | Gait imbalance (HP:0002141) | 1.83303578 |
| 106 | Sclerocornea (HP:0000647) | 1.79989319 |
| 107 | IgG deficiency (HP:0004315) | 1.79656909 |
| 108 | Cerebral hypomyelination (HP:0006808) | 1.79548160 |
| 109 | Abnormality of renal resorption (HP:0011038) | 1.78765065 |
| 110 | Increased serum ferritin (HP:0003281) | 1.78449707 |
| 111 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.78099079 |
| 112 | Cerebral edema (HP:0002181) | 1.77497265 |
| 113 | Renal tubular dysfunction (HP:0000124) | 1.76738735 |
| 114 | Autoimmune thrombocytopenia (HP:0001973) | 1.76255278 |
| 115 | Epistaxis (HP:0000421) | 1.75065791 |
| 116 | 11 pairs of ribs (HP:0000878) | 1.74301744 |
| 117 | Redundant skin (HP:0001582) | 1.72906588 |
| 118 | Nonimmune hydrops fetalis (HP:0001790) | 1.72804634 |
| 119 | Sparse eyelashes (HP:0000653) | 1.70076576 |
| 120 | Microcytic anemia (HP:0001935) | 1.69922798 |
| 121 | Concave nail (HP:0001598) | 1.69786238 |
| 122 | Mediastinal lymphadenopathy (HP:0100721) | 1.69774950 |
| 123 | Abnormality of T cells (HP:0002843) | 1.69431608 |
| 124 | Nephronophthisis (HP:0000090) | 1.69019901 |
| 125 | Type II lissencephaly (HP:0007260) | 1.67577696 |
| 126 | Glycosuria (HP:0003076) | 1.67496384 |
| 127 | Abnormality of urine glucose concentration (HP:0011016) | 1.67496384 |
| 128 | Severe visual impairment (HP:0001141) | 1.67206949 |
| 129 | Vomiting (HP:0002013) | 1.67090636 |
| 130 | Orchitis (HP:0100796) | 1.66816750 |
| 131 | Gliosis (HP:0002171) | 1.66793039 |
| 132 | Abnormal urine phosphate concentration (HP:0012599) | 1.66350205 |
| 133 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.65768209 |
| 134 | Selective tooth agenesis (HP:0001592) | 1.65706294 |
| 135 | Hypokinesia (HP:0002375) | 1.64241979 |
| 136 | Biconcave vertebral bodies (HP:0004586) | 1.63440111 |
| 137 | Prolonged neonatal jaundice (HP:0006579) | 1.62686852 |
| 138 | Basal ganglia calcification (HP:0002135) | 1.62635664 |
| 139 | Progressive microcephaly (HP:0000253) | 1.62271045 |
| 140 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.61887997 |
| 141 | Lymphoma (HP:0002665) | 1.61010924 |
| 142 | Retinal dysplasia (HP:0007973) | 1.60535239 |
| 143 | Abnormality of glycolysis (HP:0004366) | 1.57893063 |
| 144 | Amniotic constriction ring (HP:0009775) | 1.55768776 |
| 145 | Abnormality of placental membranes (HP:0011409) | 1.55768776 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 5.67605086 |
| 2 | NME2 | 4.14500152 |
| 3 | BUB1 | 3.33189624 |
| 4 | PIM2 | 3.03739937 |
| 5 | STK16 | 2.88946187 |
| 6 | EIF2AK1 | 2.76977866 |
| 7 | MAP4K2 | 2.64152345 |
| 8 | BCKDK | 2.34338914 |
| 9 | SIK3 | 2.31636569 |
| 10 | EIF2AK3 | 2.22510516 |
| 11 | IRAK4 | 2.12237746 |
| 12 | KDR | 1.99506628 |
| 13 | MAP3K12 | 1.98318514 |
| 14 | NUAK1 | 1.97805758 |
| 15 | TESK2 | 1.97519863 |
| 16 | TXK | 1.93169652 |
| 17 | TESK1 | 1.89134193 |
| 18 | ZAP70 | 1.87304591 |
| 19 | ERN1 | 1.86131468 |
| 20 | MAP4K1 | 1.83982372 |
| 21 | ADRBK2 | 1.76216384 |
| 22 | VRK1 | 1.75013556 |
| 23 | MAP3K11 | 1.68379279 |
| 24 | ACVR1B | 1.67840175 |
| 25 | MUSK | 1.67173254 |
| 26 | WEE1 | 1.58004170 |
| 27 | NME1 | 1.56216327 |
| 28 | KIT | 1.51685902 |
| 29 | BLK | 1.49529675 |
| 30 | RPS6KA4 | 1.47590609 |
| 31 | TGFBR1 | 1.47255359 |
| 32 | IRAK3 | 1.44591995 |
| 33 | BRSK2 | 1.40832897 |
| 34 | DYRK2 | 1.40410615 |
| 35 | TBK1 | 1.38850672 |
| 36 | CSNK1G3 | 1.38140106 |
| 37 | GRK1 | 1.36111320 |
| 38 | MYLK | 1.31851605 |
| 39 | CDK8 | 1.30331567 |
| 40 | WNK3 | 1.27387755 |
| 41 | ILK | 1.19446773 |
| 42 | TEC | 1.18528825 |
| 43 | BTK | 1.18467437 |
| 44 | ARAF | 1.17944527 |
| 45 | MAP2K7 | 1.16209866 |
| 46 | TSSK6 | 1.13806577 |
| 47 | MAP2K3 | 1.13246153 |
| 48 | NEK9 | 1.12726463 |
| 49 | PLK4 | 1.12364067 |
| 50 | IKBKE | 1.12121846 |
| 51 | MAPKAPK3 | 1.08271183 |
| 52 | LIMK1 | 1.08166395 |
| 53 | JAK3 | 1.07775572 |
| 54 | PDK2 | 1.07051745 |
| 55 | ZAK | 1.06719103 |
| 56 | CSNK1G2 | 1.06107994 |
| 57 | LRRK2 | 1.06034819 |
| 58 | PIK3CG | 1.05551964 |
| 59 | TYK2 | 1.05042382 |
| 60 | CSNK1G1 | 1.02260313 |
| 61 | TRIM28 | 1.01994077 |
| 62 | PHKG1 | 0.97608298 |
| 63 | PHKG2 | 0.97608298 |
| 64 | MAP3K14 | 0.97546635 |
| 65 | IKBKB | 0.96861703 |
| 66 | DYRK3 | 0.96256559 |
| 67 | DAPK3 | 0.92305264 |
| 68 | ABL2 | 0.91679529 |
| 69 | SYK | 0.91511859 |
| 70 | CCNB1 | 0.90998220 |
| 71 | BRSK1 | 0.86776351 |
| 72 | FLT3 | 0.84723822 |
| 73 | SRPK1 | 0.82258704 |
| 74 | CSNK1A1L | 0.81937500 |
| 75 | BRAF | 0.81105741 |
| 76 | ADRBK1 | 0.81096620 |
| 77 | RPS6KB2 | 0.79723253 |
| 78 | MKNK1 | 0.79071440 |
| 79 | DAPK1 | 0.75619565 |
| 80 | PIM1 | 0.75190612 |
| 81 | MAPK15 | 0.74746141 |
| 82 | IRAK1 | 0.74674362 |
| 83 | MATK | 0.74617335 |
| 84 | NEK1 | 0.74168705 |
| 85 | BMPR1B | 0.74131291 |
| 86 | GRK7 | 0.73871124 |
| 87 | PRKCI | 0.73307116 |
| 88 | PASK | 0.72817804 |
| 89 | TAOK3 | 0.72716852 |
| 90 | GRK5 | 0.71171043 |
| 91 | PLK3 | 0.70320706 |
| 92 | FRK | 0.69734480 |
| 93 | RPS6KA6 | 0.68165416 |
| 94 | CDK7 | 0.66931599 |
| 95 | LYN | 0.65949049 |
| 96 | MAPKAPK5 | 0.65357859 |
| 97 | EPHB2 | 0.65308635 |
| 98 | SCYL2 | 0.65288123 |
| 99 | PINK1 | 0.64240962 |
| 100 | MST4 | 0.64028967 |
| 101 | ATR | 0.63078595 |
| 102 | EIF2AK2 | 0.62907097 |
| 103 | INSRR | 0.62682241 |
| 104 | LMTK2 | 0.61840586 |
| 105 | EPHA2 | 0.61074114 |
| 106 | PBK | 0.60390827 |
| 107 | CAMKK2 | 0.58532486 |
| 108 | TLK1 | 0.57848251 |
| 109 | RPS6KL1 | 0.55590040 |
| 110 | RPS6KC1 | 0.55590040 |
| 111 | MAP3K3 | 0.55026498 |
| 112 | AURKB | 0.53738443 |
| 113 | PKN1 | 0.51816235 |
| 114 | PRKG2 | 0.51446472 |
| 115 | MAP2K6 | 0.51379722 |
| 116 | CSNK2A1 | 0.51053212 |
| 117 | PAK1 | 0.50885132 |
| 118 | PLK1 | 0.49289444 |
| 119 | RPS6KA5 | 0.49264290 |
| 120 | CSNK2A2 | 0.49001744 |
| 121 | CHUK | 0.48769751 |
| 122 | CDC7 | 0.48478480 |
| 123 | AURKA | 0.47854814 |
| 124 | STK4 | 0.47840780 |
| 125 | TGFBR2 | 0.45489750 |
| 126 | MAPKAPK2 | 0.44933768 |
| 127 | MARK3 | 0.44931960 |
| 128 | OXSR1 | 0.44753154 |
| 129 | NLK | 0.44716359 |
| 130 | PAK4 | 0.44103335 |
| 131 | MAPK13 | 0.44076313 |
| 132 | CDK19 | 0.43474302 |
| 133 | TAOK2 | 0.43255835 |
| 134 | GRK6 | 0.42290688 |
| 135 | PRKCD | 0.41643577 |
| 136 | EPHA3 | 0.41201839 |
| 137 | PRKCG | 0.38788811 |
| 138 | PRKCE | 0.38219285 |
| 139 | CSF1R | 0.38212072 |
| 140 | MAPK4 | 0.36836928 |
| 141 | MAP3K4 | 0.36345215 |
| 142 | CHEK2 | 0.35453395 |
| 143 | DAPK2 | 0.34962412 |
| 144 | CSNK1A1 | 0.33462503 |
| 145 | PRKCQ | 0.32535328 |
| 146 | PRKACA | 0.31405400 |
| 147 | CAMK2G | 0.29589461 |
| 148 | TIE1 | 0.29266277 |
| 149 | WNK4 | 0.27253492 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.43178097 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 4.35658966 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.64861623 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 2.94119620 |
| 5 | Protein export_Homo sapiens_hsa03060 | 2.87877590 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 2.54311751 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 2.50718860 |
| 8 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.49732399 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.26431327 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.23923014 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 2.23699698 |
| 12 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.98537595 |
| 13 | Spliceosome_Homo sapiens_hsa03040 | 1.97872151 |
| 14 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.96910358 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.92760695 |
| 16 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.86572486 |
| 17 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.78467314 |
| 18 | Homologous recombination_Homo sapiens_hsa03440 | 1.75817027 |
| 19 | Sulfur relay system_Homo sapiens_hsa04122 | 1.67603994 |
| 20 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.53672020 |
| 21 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.53310759 |
| 22 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.49140215 |
| 23 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.45300555 |
| 24 | Huntingtons disease_Homo sapiens_hsa05016 | 1.45013718 |
| 25 | RNA transport_Homo sapiens_hsa03013 | 1.35007758 |
| 26 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.33388900 |
| 27 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.31568090 |
| 28 | Purine metabolism_Homo sapiens_hsa00230 | 1.24540793 |
| 29 | RNA degradation_Homo sapiens_hsa03018 | 1.23796689 |
| 30 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.19815610 |
| 31 | Alzheimers disease_Homo sapiens_hsa05010 | 1.18749391 |
| 32 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.18481997 |
| 33 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.17240517 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 1.16712465 |
| 35 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.16575613 |
| 36 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.14597978 |
| 37 | Asthma_Homo sapiens_hsa05310 | 1.09196884 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.07128901 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.04915644 |
| 40 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.04233017 |
| 41 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.03229337 |
| 42 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.03089002 |
| 43 | Cell cycle_Homo sapiens_hsa04110 | 1.01731396 |
| 44 | Allograft rejection_Homo sapiens_hsa05330 | 1.00393412 |
| 45 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.96816370 |
| 46 | Leishmaniasis_Homo sapiens_hsa05140 | 0.96756735 |
| 47 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.95886673 |
| 48 | Galactose metabolism_Homo sapiens_hsa00052 | 0.95715422 |
| 49 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.93567519 |
| 50 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.92614147 |
| 51 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.91586651 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.91214313 |
| 53 | Phototransduction_Homo sapiens_hsa04744 | 0.88836339 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.88833524 |
| 55 | Shigellosis_Homo sapiens_hsa05131 | 0.87894504 |
| 56 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.85990019 |
| 57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.84661344 |
| 58 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.84294992 |
| 59 | Measles_Homo sapiens_hsa05162 | 0.84288634 |
| 60 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.83618522 |
| 61 | Basal transcription factors_Homo sapiens_hsa03022 | 0.83228399 |
| 62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82878626 |
| 63 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.80657632 |
| 64 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.80223596 |
| 65 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.77916129 |
| 66 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.77082673 |
| 67 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.76864956 |
| 68 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.76576495 |
| 69 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.76217028 |
| 70 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.74670982 |
| 71 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.74664365 |
| 72 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.74167109 |
| 73 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.70958572 |
| 74 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.69834897 |
| 75 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.68423491 |
| 76 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.68026610 |
| 77 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.66311851 |
| 78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65828096 |
| 79 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.65752964 |
| 80 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.65432789 |
| 81 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.64527970 |
| 82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.62993748 |
| 83 | Peroxisome_Homo sapiens_hsa04146 | 0.59957147 |
| 84 | Pertussis_Homo sapiens_hsa05133 | 0.58145803 |
| 85 | Metabolic pathways_Homo sapiens_hsa01100 | 0.57406502 |
| 86 | Apoptosis_Homo sapiens_hsa04210 | 0.56922571 |
| 87 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.56820301 |
| 88 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.56209433 |
| 89 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.55250467 |
| 90 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.54681637 |
| 91 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.52600579 |
| 92 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.51501515 |
| 93 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.50879521 |
| 94 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.50588544 |
| 95 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50420702 |
| 96 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.49543961 |
| 97 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.49494667 |
| 98 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.49071565 |
| 99 | Carbon metabolism_Homo sapiens_hsa01200 | 0.48055895 |
| 100 | Influenza A_Homo sapiens_hsa05164 | 0.47833627 |
| 101 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.47553397 |
| 102 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.47120075 |
| 103 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.47002071 |
| 104 | Lysosome_Homo sapiens_hsa04142 | 0.46676859 |
| 105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.45506723 |
| 106 | Phagosome_Homo sapiens_hsa04145 | 0.44623695 |
| 107 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.44250853 |
| 108 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.44130547 |
| 109 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.43923635 |
| 110 | Thyroid cancer_Homo sapiens_hsa05216 | 0.43712928 |
| 111 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.42818513 |
| 112 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.42328467 |
| 113 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.41005026 |
| 114 | Malaria_Homo sapiens_hsa05144 | 0.40496453 |
| 115 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.39211340 |
| 116 | Hepatitis B_Homo sapiens_hsa05161 | 0.39172608 |
| 117 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.37982424 |
| 118 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.37436050 |
| 119 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.36494063 |
| 120 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.36266077 |
| 121 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.36161459 |
| 122 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.36012838 |
| 123 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.35597917 |
| 124 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.35505039 |
| 125 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.35320098 |
| 126 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.35016677 |
| 127 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.33853471 |
| 128 | Tuberculosis_Homo sapiens_hsa05152 | 0.33535055 |
| 129 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.32343048 |
| 130 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.30694970 |
| 131 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.30589161 |
| 132 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.29844092 |
| 133 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.28881701 |
| 134 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.28249505 |
| 135 | Mineral absorption_Homo sapiens_hsa04978 | 0.27774986 |

